PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Pfizer (PFE) Tops Q1 EPS by 2c, Lowers FY Guidance Due to Exchange Rates
April 28, 2015 7:05 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.51, $0.02 better than the analyst estimate of $0.49. Revenue for the quarter came in at $10.86 billion versus the consensus estimate of $10.79 billion.
Pfizer's 2015 financial guidance was updated solely to reflect changes in foreign exchange rates in relation to the U.S. dollar from mid-January 2015 to mid-April 2015, primarily the weakening of the euro.
Pfizer sees FY2015 EPS of $1.95-$2.05, versus prior guidance of $2.00-$2.10 and the consensus of $2.07. Pfizer sees FY2015 revenue of $44-46 million, versus prior guidance of $44.5-46.5 million and the consensus of $45.94... More
